中新网8月11日电(赵方园)随着疫苗接种工作的推进，二价HPV疫苗的市场价格也在不断下降。山东省近日披露的采购成交公告显示，二价HPV疫苗单支中标价格已降至27.5元，这一价格创下新低，有望进一步推动疫苗接种率的提升，尤其是针对适龄女孩的预防接种工作。
与此同时，国家医保局公布了2024年国家医保目录初审通过的440个药品，显示了国家在医疗保障方面的持续努力，旨在通过医保目录的调整来更好地满足人民群众的医疗需求，同时也对医疗行业提出了更高的要求，以防止骗取医保基金的行为。
在行业监管方面，国家医保局召开会议，强调了打击骗取医保基金工作的决心和措施。会议指出，要加强对定点医药机构的监管，通过智能监控系统提高药品追溯码的覆盖率，以防范和打击医疗欺诈行为。
江苏昆山卫健委对网传民营医疗机构“要求医生让患者消费到7000元”的情况进行了调查，并成立了专项调查组。这一行动显示了政府部门对维护患者权益的高度重视，将依法依规严肃处理相关问题，保障患者的合法权益。
在行业动态方面，深圳市达科为生物技术股份有限公司的创业板IPO因主动撤回注册申请文件而终止，这为其他在IPO过程中遇到问题的企业提供了警示。
此外，汇宇制药董事长丁兆因涉嫌短线交易公司股票被中国证监会立案调查。汇宇制药在公告中强调，本次调查不会影响公司的董事会运作及日常经营活动，丁兆将积极配合中国证监会的调查工作。
香雪制药的股价在短期内出现了显著上涨，公司对此进行了关注并发布公告，称公司股价可能存在非理性炒作等情形，提醒投资者注意投资风险。
综上所述，在医疗健康领域，价格下调的二价HPV疫苗有望促进疫苗接种工作的普及，国家医保局和相关部门对医疗保障和行业监管的加强，以及企业IPO进程中的积极应对和规范操作，都是当前医疗健康行业关注的焦点。同时，对于个别企业或个人的不当行为，监管部门也在采取措施进行处理，以维护市场的公平和秩序。
英语如下：
Title: “HPV Vaccine Price Hits New Low, Biotech Chief Executive Under Investigation by Regulatory Authorities”
Keywords: HPV vaccine low price, medical insurance audit, high-level executive investigation
Content:
BEIJING, Aug. 11 (Xinhua) — With the advancement of vaccination efforts, the market price of the bivalent HPV vaccine is declining. A recent procurement tender announcement by Shandong Province revealed that the price per vial of the bivalent HPV vaccine has been reduced to 27.5 yuan, setting a new low and potentially boosting vaccination rates, particularly for preventive measures targeting young girls.
Meanwhile, the National Medical Insurance Administration announced that 440 drugs have passed the preliminary review for the 2024 National Medical Insurance List, showcasing the government’s ongoing efforts to meet the healthcare needs of the public through adjustments to the insurance list, while also raising the bar for the medical industry to prevent fraudulent use of medical insurance funds.
In terms of industry regulation, the National Medical Insurance Administration convened a meeting to emphasize the determination and measures to combat fraudulent use of medical insurance funds. The meeting pointed out the need to strengthen supervision over designated medical institutions, improve the coverage of drug traceability codes through intelligent monitoring systems, and prevent and combat medical fraud.
The health commission of Kunshan, Jiangsu Province, conducted an investigation into a report that a private medical institution in the city had allegedly required doctors to ensure patients spent 7,000 yuan, indicating the government’s high regard for protecting patient rights and its commitment to dealing with the issue in accordance with the law to safeguard patients’ rights.
In terms of industry dynamics, the initial public offering (IPO) of Shenzhen Dakewei Biotechnology Co., Ltd. on the创业板 was terminated after the company voluntarily withdrew its registration application documents, serving as a warning to other companies facing issues during the IPO process.
Furthermore, the chairman of Huilong Pharmaceutical, Ding Zhao, was investigated by the China Securities Regulatory Commission (CSRC) for alleged short-term trading of company shares. Huilong Pharmaceutical emphasized in its announcement that the investigation would not affect the company’s board operations and daily business activities, and Ding Zhao would cooperate fully with the CSRC’s investigation.
The stock price of Xiangyu Pharmaceutical showed significant gains in the short term, prompting the company to issue a statement and a notice that the stock price may be the result of irrational speculation and urged investors to be cautious about investment risks.
In summary, the declining price of the bivalent HPV vaccine is expected to promote the widespread of vaccination efforts, and the strengthening of medical insurance and industry regulation by relevant departments, as well as the proactive response and proper conduct of companies in the IPO process, are the focal points of attention in the medical health industry. At the same time, regulatory measures are being taken to address inappropriate behavior by individual companies or individuals to maintain fair and orderly market conditions.
【来源】http://www.chinanews.com/life/2024/08-11/10267330.shtml
Views: 2